Prolonged dual antiplatelet therapy for Chinese ACS patients undergoing emergency PCI with drug-eluting stents: Benefits and risks

Prolonged dual antiplatelet therapy for Chinese ACS patients undergoing emergency PCI with drug-eluting stents: Benefits and risks

BackgroundIn patients with acute coronary syndrome (ACS), prolonged dual antiplatelet therapy (DAPT) may reduce ischemic events and increase the risks of bleeding events differently in different ethnic groups. However, whether prolonged DAPT in Chinese patients with ACS following emergency percutane...

Full description

Bibliographic Details
Main Authors: Yong Zhang, Chao Chu, Zhong Zhong, Yong-bai Luo, Fei-Fei Ning, Ning Guo
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
dual antiplatelet therapy (DAPT)
acute coronary syndrome (ACS)
major adverse cardiovascular and cerebrovascular event (MACCE)
composite bleeding event
emergency percutaneous coronary intervention (PCI)
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1080673/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1080673/full

Similar Items